Prevalence and correlates of post-prandial hyperglycaemia in a large sample of patients with type 2 diabetes mellitus

被引:121
作者
Bonora, E
Corrao, G
Bagnardi, V
Ceriello, A
Comaschi, M
Montanari, P
Meigs, JB
机构
[1] Univ Hosp Verona, Div Endocrinol & Metab Dis, I-37126 Verona, Italy
[2] Univ Milan, Dept Stat, Biostat Unit, Milan, Italy
[3] Univ Warwick, Warwick Med Sch, Coventry CV4 7AL, W Midlands, England
[4] Arenzano Hosp, Dept Internal Med, Genoa, Italy
[5] Novartis Italy, Med Board, Milan, Italy
[6] Massachusetts Gen Hosp, Dept Med, Div Gen Med, Boston, MA 02114 USA
[7] Harvard Univ, Sch Med, Boston, MA 02114 USA
关键词
HbA(1c); metabolic control; post-prandial glucose; pre-prandial glucose; type; 2; diabetes;
D O I
10.1007/s00125-006-0203-x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Post-prandial glucose may be a risk factor for cardiovascular disease and chronic diabetic complications. We tested the hypothesis that post-prandial hyperglycaemia is common in type 2 diabetes, even among patients in apparently good glycaemic control, and that simple clinical characteristics identify subsets of diabetic patients with frequent post-prandial hyperglycaemia. Three self-assessed daily blood glucose profiles over a 1-week period, including 18 glucose readings before and 2 h after meals, were obtained from 3,284 unselected outpatients (men 51%; age 63 +/- 10 years) with non-insulin-treated type 2 diabetes mellitus attending 500 different diabetes clinics operating throughout Italy. A post-prandial blood glucose value > 8.89 mmol/l (160 mg/dl) was recorded at least once in 84% of patients, and 81% of patients had at least one Delta glucose >= 2.22 mmol/l (40 mg/dl). Among patients with apparently good metabolic control, 38% had > 40% of post-prandial blood glucose readings > 8.89 mmol/l (>= 4 of 9 meals in total), and 36% had > 40% Delta glucose >= 2.22 mmol/l. In multivariate analysis adjusted for pre-prandial glucose levels, older age, longer duration of diabetes, absence of obesity, hyperlipidaemia and hypertension, as well as treatment with sulfonylureas, were significantly associated with greater glucose excursions after meals. These results indicate that post-prandial hyperglycaemia is a very frequent phenomenon in patients with type 2 diabetes mellitus on active treatment; can occur even when metabolic control is apparently good; and can be predicted by simple clinical features.
引用
收藏
页码:846 / 854
页数:9
相关论文
共 45 条
[1]   Cardiovascular events and correlates in the Veterans Affairs diabetes feasibility trial - Veterans Affairs Cooperative Study on gylcemic control and complications in type II diabetes [J].
Abraira, C ;
Colwell, J ;
Nuttall, F ;
Sawin, CT ;
Henderson, W ;
Comstock, JP ;
Emanuele, NV ;
Levin, SR ;
Pacold, I ;
Lee, HS ;
Silbert, CK ;
Cxypoliski, R ;
Vasquez, M ;
Kernan, D ;
Niewoehner, C ;
Backes, M ;
Bradley, M ;
Bradley, M ;
Crow, R ;
Rubino, F ;
Bushnell, D ;
Pfeifer, M ;
Service, FJ ;
Howard, B ;
Chew, E ;
Hoogwerf, B ;
Seigel, D ;
Clark, CM ;
Olefsky, JM ;
Porte, D ;
Sussman, KE ;
Johnson, N ;
Christine, B ;
Tir, K ;
Sather, M ;
Day, P ;
Morgan, N ;
Deykin, D ;
Gold, J ;
Huang, P .
ARCHIVES OF INTERNAL MEDICINE, 1997, 157 (02) :181-188
[2]  
American Diabetes Association, 2001, Diabetes Care, V24, P775
[3]   Reduction of postprandial hyperglycemia and frequency of hypoglycemia in IDDM patients on insulin-analog treatment [J].
Anderson, JH ;
Brunelle, RL ;
Koivisto, VA ;
Pfutzner, A ;
Trautmann, ME ;
Vignati, L ;
DiMarchi, R ;
Bowen, KM ;
Cameron, DP ;
Nankervis, AJ ;
Roberts, AP ;
Zimmet, P ;
Borkenstein, MH ;
Schernthaner, G ;
Waldhausl, WK ;
DeLeeuw, IH ;
Fery, F ;
Scheen, A ;
Somers, G ;
Fettes, IM ;
Tildesley, HD ;
Toth, EL ;
Viikari, J ;
Altman, JJ ;
Bougneres, PF ;
Drouin, P ;
Fossati, P ;
Guillausseau, PJ ;
Marechaud, E ;
Riou, JP ;
Selam, JL ;
Vialettes, PB ;
Beyer, J ;
Federlin, K ;
Fussganger, RD ;
Gries, FA ;
Jastram, HU ;
Koop, I ;
Landgraf, R ;
Rosak, C ;
Schatz, H ;
SchulzeSchleppinghoff, B ;
Seif, FJ ;
Stoeckmann, F ;
Karasik, A ;
Weitzman, S ;
Andreani, D ;
Bompiani, G ;
Crepaldi, G ;
Giorgino, R .
DIABETES, 1997, 46 (02) :265-270
[4]  
[Anonymous], 1999, Diabet Med, V16, P716
[5]  
[Anonymous], 2005, DIABETES CARE, V28, pS4
[6]  
[Anonymous], 1982, Diabetes, V31 Suppl 5, P1
[7]   Nonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetes [J].
Avignon, A ;
Radauceanu, A ;
Monnier, L .
DIABETES CARE, 1997, 20 (12) :1822-1826
[8]  
Bonora E, 2002, INT J CLIN PRACT, P5
[9]   Plasma glucose levels throughout the day and HbA1c interrelationships in type 2 diabetes -: Implications for treatment and monitoring of metabolic control [J].
Bonora, E ;
Calcaterra, F ;
Lombardi, S ;
Bonfante, N ;
Formentini, G ;
Bonadonna, RC ;
Muggeo, M .
DIABETES CARE, 2001, 24 (12) :2023-2029
[10]   Postprandial blood glucose as a risk factor for cardiovascular disease in Type II diabetes: the epidemiological evidence [J].
Bonora, E ;
Muggeo, M .
DIABETOLOGIA, 2001, 44 (12) :2107-2114